Fundz

PsychoGenics

New Jersey, United States · Biotechnology · 150 employees

PsychoGenics is a leading biotechnology company dedicated to revolutionizing drug discovery through AI-enabled platforms. They have pioneered the translation of rodent behavioral and physiological responses into high-throughput phenotyping. Their platforms have facilitated partnerships with major pharmaceutical companies, leading to several novel compounds in advanced development. PsychoGenics als

Funding history

  • Series seed — $3.0M — Aug 2024

Recent signals

  • Oct 08, 2024: PsychoGenics Awarded $80 Million NIH Contract to Test Novel Therapeutics for Pain
  • Aug 28, 2024: Raised $3.0M in Series seed

See plans & pricing → Track PsychoGenics’s funding, hiring, and signals — with verified contacts — on Fundz.